BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Treatment
5 results:

  • 1. Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross liver Study Group.
    Takaki S; Kurosaki M; Mori N; Tsuji K; Ochi H; Marusawa H; Nakamura S; Tada T; Narita R; Uchida Y; Akahane T; Kondo M; Kusakabe A; Furuta K; Kobashi H; Arai H; Nonogi M; Tamada T; Hasebe C; Ogawa C; Sato T; Tamaki N; Yasui Y; Tsuchiya K; Izumi N
    Invest New Drugs; 2023 Apr; 41(2):340-349. PubMed ID: 36995548
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.
    Gantois D; Guilbaud T; Scemama U; Girard E; Picaud O; Lefevre M; Elgani M; Hamidou Z; Moutardier V; Balandraud P; Chirica M; Barbier L; Fuks D; Birnbaum DJ
    Langenbecks Arch Surg; 2022 Feb; 407(1):153-165. PubMed ID: 34373941
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
    Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
    Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.
    Diouf M; Bonnetain F; Barbare JC; Bouché O; Dahan L; Paoletti X; Filleron T
    Oncologist; 2015 Jan; 20(1):62-71. PubMed ID: 25542450
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival.
    Géraud C; Mogler C; Runge A; Evdokimov K; Lu S; Schledzewski K; Arnold B; Hämmerling G; Koch PS; Breuhahn K; Longerich T; Marx A; Weiss C; Damm F; Schmieder A; Schirmacher P; Augustin HG; Goerdt S
    Liver Int; 2013 Oct; 33(9):1428-40. PubMed ID: 23870052
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.